 |
| Jiafu Ji, MD, Professor, President, Cancer Hospital of Beijing University Chair of Gastric Cancer Society of Chinese Anti-Cancer Association Source: Oncology Frontier(肿瘤瞭望) |
At 11th IGCC(June 4-6, 2015, Soo Paulo, Brazil), representing
China Gastric Cancer Society, Dr. Ji took over the flag of IGCC from present President
of IGCA, Dr. Bruzo Zilberstein, for hosting the next congress, shared his
thought with “Oncology Frontier”.
 |
| Dr. Ji and Dr. Zilberstein Souce:Wechat: CHJCACNR |
1. Late stage of gastric cancer treatment
Dr. Jiafu Ji: 70% gastric cancer patients who seek medical
treatment in China already in the late stage, this is very different from the
situation in Japan and South Korea, which more than 50% are in early stage.
That's why our treatment models, which is called multidisciplinary
team (MDT) model, is different from Japan and Korean. MDT is surgery based.
 |
| Dr. Jiafu Ji Souce:Wechat: CHJCACNR |
2. The Standardization and personalized comprehensive treatment in gastric cancer
Dr. Ji: Surgery is the standard treatment for advanced
gastric cancer. There are about 2,000 hospitals in China that are capable of performing
the operation in gastric cancer patients with great discrepancy. First we
established a standardized treatment model based on guidelines and consensus,
of course in the real practice, you have to consider patient's acceptance and
cost issue.
In the last 10 years, our team(Cancer hospital of Beijing
University) have published textbooks, videos, periodical workshop trips and
symposiums, and trained more than 6,000 senior physicians. I think Chinese
gastric cancer surgeon's skills have won widely recognition in the world.
Only after we have got surgery standardized, then we have
appropriate supplementary treatment, including chemotherapy, immunotherapy and
radiotherapy etc. to get to precision or personalized treatment next step. This
is what we are doing now.
 |
| CGCA members at 11th IGCC Souce:Wechat: CHJCACNR |
3. What to expect for 12th IGCC?
Dr. Ji: I still remember the moment vividly of winning the
host 12th IGCC in 2013. I think this demonstrated that China has won the worldwide
gastric cancer oncologist peers' recognition, after several generation's
Chinese gastric oncologists hard work in treatment and research.
However, about 500,000 new gastric cancer patients will be
diagnosed each year in China, and in a annual accumulated rate of 3% increase
according to WHO data. Majority of the patients are in advanced stage. Patients
and the government are facing great burden.
The 12th IGCC held in China will be a great opportunity to
raise the awareness in public and to the government. Questions like how to prevent gastric cancer?
Can we do early detection? How to treat appropriately? How to reduce recurrence?
How to foster multiple disciplinary team
collaboration for patient' care? How to improve patient's life quality?
I hope the hosting of 12th IGCC will push us to work harder
to advance to a higher stage to address above questions, especially on prevention,
early detection, research and appropriate standard treatment procedures.
References:
1. IGCC 访谈，中国最强音--季加孚院长：胃癌的标准化和个体化综合治疗 "肿瘤瞭望" WeChat http://mp.weixin.qq.com/s?__biz=MzA4MDM4MzExMA==&mid=207851158&idx=1&sn=df8e8c2e5e988dfd2859b4c8a10c536a#rd
2. 中国正式成为世界胃癌大会主办国 "全球肿瘤快讯" WeChat http://mp.weixin.qq.com/s?__biz=MzA3MjM4MDMzNg==&mid=206233706&idx=2&sn=2af5e6f12c3a5d26e4455379140862a6#rd 转载自中国癌症研究英文杂志微信公共号：CHJCACNR
3. 中国梦，世界梦--今天成为现实--第11届世界胃癌大会纪事 "全球肿瘤快讯" WeChat http://mp.weixin.qq.com/s?__biz=MzA3MjM4MDMzNg==&mid=206233706&idx=1&sn=604032e4e125f5d15e1276c6fd9db734#rd 转载自中国癌症研究英文杂志 微信公共号：CHJCACNR
No comments:
Post a Comment